> ## Content Index
> Fetch the complete content index at: https://www.fdaweb.com/llms.txt
> Use this file to discover other available public pages before exploring further.

# Panel to Review Siga Tech Smallpox NDA
- URL: https://www.fdaweb.com/panel-to-review-siga-tech-smallpox-nda/
- Published: 2018-04-13T12:00:00.000Z
- Updated: 2026-09-14T23:59:00.000Z
- Author: David McFarland
- Tags: FDA Policy/General, #legacy-id-D5141215

*Federal Register* notice: FDA has announced a 5/1 Antimicrobial Drugs Advisory Committee meeting. Panel members are scheduled to discuss a Siga Technologies NDA for tecovirimat for the proposed indication of treating smallpox disease caused by variola virus in adults and pediatric patients. The product was developed under the agency’s Animal Rule (21 CFR part 314, subpart I). To view the notice, click [here](https://www.gpo.gov/fdsys/pkg/FR-2018-04-13/pdf/2018-07747.pdf?ref=fdaweb.com).